GeneDx Holdings (WGS) EBT (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly EBT of -$62.4 million for Q1 2026, down 926.29% year-over-year from $7.6 million in Q1 2025, and down 242.4% quarter-over-quarter from -$18.2 million in Q4 2025.
GeneDx Holdings (WGS) EBT (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported EBT for 7 consecutive years, with -$62.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 926.29% year-over-year to -$62.4 million; the TTM figure through Mar 2026 stood at -$77.5 million (down 101.81% YoY), while the FY2025 annual figure was -$21.1 million, up 59.84% from the prior year.
- EBT slipped to -$62.4 million in Q1 2026 per WGS's latest filing, from -$18.2 million in the prior quarter.
- Across five years, EBT topped out at $10.6 million in Q2 2025 and bottomed at -$308.7 million in Q4 2022.
- Historically, EBT has averaged -$53.6 million across 5 years, with a median of -$29.4 million in 2024.
- Annual changes were most pronounced in 2025 — EBT surged 135.97% — and 2026, when it plunged 926.29%.
- GeneDx Holdings' EBT stood at -$308.7 million in 2022, then soared by 91.52% to -$26.2 million in 2023, then soared by 120.68% to $5.4 million in 2024, then sank by 436.72% to -$18.2 million in 2025, then sank by 242.4% to -$62.4 million in 2026.
- Business Quant data shows WGS's EBT at -$62.4 million in Q1 2026, -$18.2 million in Q4 2025, and -$7.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.92 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 1.08 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -67.23 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 408.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 301.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 417.22 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 260.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 289.40 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 386.40 Mn |
| 10 | GeneDx Holdings | 2.65 Bn | 2.52 Bn | 78.24 Mn | -18.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.26 Mn |
| Mar 31, 2026 | -62.42 Mn |
| Dec 31, 2025 | -18.23 Mn |
| Sep 30, 2025 | -7.39 Mn |
| Jun 30, 2025 | 10.56 Mn |
| Mar 31, 2025 | -6.08 Mn |
| Dec 31, 2024 | 5.41 Mn |
| Sep 30, 2024 | -8.36 Mn |
| Jun 30, 2024 | -29.36 Mn |
| Mar 31, 2024 | -20.32 Mn |
| Dec 31, 2023 | -26.18 Mn |
| Sep 30, 2023 | -42.46 Mn |
| Jun 30, 2023 | -46.92 Mn |
| Mar 31, 2023 | -61.14 Mn |
| Dec 31, 2022 | -308.67 Mn |
| Sep 30, 2022 | -77.65 Mn |
| Jun 30, 2022 | -134.82 Mn |
| Mar 31, 2022 | -76.90 Mn |
| Dec 31, 2021 | -40.19 Mn |
| Sep 30, 2021 | 32.73 Mn |